Home Featured Page 173

Featured

Latest

Megan Portnoy MS – Ontological Design, Psychedelic Spaces, and Integrating Rigor

The Psychedelic News Feed: October 6 – 12, 2025

Recovered or Reimagined? Samuli Kangaslampi on Psychedelics and Autobiographical Recall

Psychedelic Futures – Nowak Society featuring Joe Moore

Q2 2025: Oregon Psilocybin Services Update

Psyched Wellness and the National Research Council of Canada Announce Preliminary...

Cybin Announces Additional Adelia Milestone Achievement

PT304 – Jerry B. Brown, Ph.D. – Vital Psychedelic Conversations

Cybin-Sponsored Feasibility Study Using Kernel Flow Technology Currently Recruiting Participants

Filament Health Announces Second Patent Issuance

Tryp Therapeutics Initiates Enrollment for Binge Eating Disorder Study in Partnership...

COMPASS Pathways and partners launch The Centre for Mental Health Research...

Awakn Life Sciences Announces Closing of Private Placement

PT303 – Adam Bramlage – Cannabis, Microdosing, and Our Evolutionary Connection...

Psychedelic Bulletin: MINDCURE – A Canary in the Psychedelic Coal Mine?

1...172173174...299 Page 173 of 299

Megan Portnoy MS – Ontological Design, Psychedelic Spaces, and Integrating Rigor

The Psychedelic News Feed: October 6 – 12, 2025

Recovered or Reimagined? Samuli Kangaslampi on Psychedelics and Autobiographical Recall

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Megan Portnoy MS – Ontological Design, Psychedelic Spaces, and Integrating Rigor

The Psychedelic News Feed: October 6 – 12, 2025

Recovered or Reimagined? Samuli Kangaslampi on Psychedelics and Autobiographical Recall

Psychedelic Futures – Nowak Society featuring Joe Moore

Q2 2025: Oregon Psilocybin Services Update

Psyched Wellness and the National Research Council of Canada Announce Preliminary...

Cybin Announces Additional Adelia Milestone Achievement

PT304 – Jerry B. Brown, Ph.D. – Vital Psychedelic Conversations

Cybin-Sponsored Feasibility Study Using Kernel Flow Technology Currently Recruiting Participants

Filament Health Announces Second Patent Issuance

Tryp Therapeutics Initiates Enrollment for Binge Eating Disorder Study in Partnership...

COMPASS Pathways and partners launch The Centre for Mental Health Research...

Awakn Life Sciences Announces Closing of Private Placement

PT303 – Adam Bramlage – Cannabis, Microdosing, and Our Evolutionary Connection...

Psychedelic Bulletin: MINDCURE – A Canary in the Psychedelic Coal Mine?

EDITOR PICKS

Megan Portnoy MS – Ontological Design, Psychedelic Spaces, and Integrating Rigor

The Psychedelic News Feed: October 6 – 12, 2025

Recovered or Reimagined? Samuli Kangaslampi on Psychedelics and Autobiographical Recall

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY